Solid Biosciences Inc.
corporate_fare Company Profile
Solid Biosciences Inc. (NASDAQ:SLDB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for SLDB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-14, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 12 rated 8 or above. Recent SEC coverage for SLDB spans SCHEDULE 13D/A, 8-K, 10-Q, PRE 14A.
Recent high-impact activity:
- Perceptive Advisors Lifts Solid Biosciences Stake to 11.2% with $0.001 Pre-Funded Warrants
- Solid Biosciences Replaces Exhausted $85M ATM with New $200M Equity Program
- Solid Biosciences Q2 Loss Widens to $54.8M, Cash Runway Extended to Mid-2028
- RA Capital Management Boosts Stake in Solid Biosciences with $22M Share Purchase
- Shareholders Approve Doubling Authorized Common Stock to 480 Million Shares
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for SLDB, detected from its recent SEC filings · based on capital-structure filings through 2026-08-06.
New $200M ATM Program Established · Prior $85M ATM Fully Drawn
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →